查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1684344

醫療保健生物融合市場，按技術、按解決方案類型、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Healthcare Bioconvergence Market, By Technology, By Solution Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年醫療保健生物融合市場規模價值為 143,920.32 百萬美元，2025 年至 2032 年期間的複合年成長率為 6.90%。

醫療保健生物融合市場-市場動態

**人工智慧藥物研發的進步加速了市場的成長**

人工智慧驅動的藥物發現正在透過加速新療法的識別和最佳化治療方法的開發，徹底改變醫療保健生物融合市場。領先的製藥公司和生物技術新創公司正在將人工智慧與生物資料相結合，以增強精準醫療並簡化藥物篩選。例如，FDA 已經批准了用於藥物再利用的人工智慧驅動平台，而 Insilico Medicine 和 BenevolentAI 等公司正在利用深度學習來識別有前景的候選藥物。此外，人工智慧驅動的演算法正在基因組學中用於分析大量資料集，有助於早期疾病檢測。美國國立衛生研究院 (NIH) 資助了多個基於人工智慧的研究項目，以提高藥物功效並縮短開發時間。隨著人工智慧降低成本並提高效率，製藥公司擴大與科技公司合作，利用機器學習進行藥物研發。然而，監管挑戰和資料隱私問題仍然是充分發揮人工智慧在藥物開發方面的潛力的主要障礙。儘管有這些挑戰，人工智慧和生物技術的持續融合將重塑現代醫學。

醫療保健生物融合市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 6.90%

根據技術細分，預計人工智慧和巨量資料整合將在 2024 年佔據最大市場佔有率

根據解決方案類型細分，生物製藥是 2024 年領先的解決方案類型

根據應用程式細分，個人化醫療是 2024 年的領先應用

從地區來看，北美是 2024 年最大的收入來源

醫療保健生物融合市場-細分分析：

全球醫療保健生物融合市場根據技術、解決方案類型、應用、最終用戶和地區進行細分。

市場根據科技分為四大類：合成生物學、生物電子學、奈米技術、人工智慧與巨量資料整合。人工智慧和巨量資料整合引領醫療生物融合市場，推動個人化醫療和預測分析。隨後，合成生物學徹底改變了基因編輯和生物材料。奈米技術位居第二，可以實現有針對性的藥物輸送。生物電子學具有巨大的潛力，可增強神經刺激和即時健康監測應用。

根據解決方案類型，市場分為四類：生物製藥、組織工程、生物感測器和人工智慧驅動的診斷。生物製藥主導醫療生物融合市場，推動標靶治療和再生醫學的進步。隨後，人工智慧驅動的診斷徹底改變了早期疾病檢測和精準醫療。接下來是組織工程，它能夠實現器官再生。生物感測器在即時監測和個人化醫療保健解決方案中發揮著至關重要的作用。

醫療保健生物融合市場-地理洞察

受生物技術、人工智慧（AI）和精準醫療領域強勁投資的推動，北美在醫療生物融合市場中佔據主導地位。美國是主要生物科技公司和研究機構的所在地，製藥公司和人工智慧新創企業之間的合作日益增多。美國國立衛生研究院的人工智慧驅動研究計畫等政府措施進一步支持了市場成長。歐洲緊隨其後，德國、英國和法國等國家在合成生物學、生物工程和數位健康創新方面取得了進展。歐盟委員會已啟動資助計劃，促進生物融合研究。在亞太地區，在政府政策和私營部門投資的推動下，中國、日本和韓國正在迅速擴大其生物技術和人工智慧能力。尤其是中國，在基因編輯和人工智慧診斷領域處於領先地位。同時，中東和拉丁美洲是新興市場，對個人化醫療和生物資訊學的投資不斷增加。然而，人工智慧和基因改造的監管複雜性和道德問題對不同地區的市場擴張構成了挑戰。

醫療保健生物融合市場-競爭格局：

醫療保健生物融合市場競爭激烈，主要參與者專注於整合生物技術、人工智慧 (AI)、奈米技術和工程來推動醫療創新。輝瑞、諾華和羅氏等領先的製藥公司正在投資人工智慧驅動的藥物研發和生物工程解決方案。 IBM Watson Health 和 Google DeepMind 等科技公司正在透過機器學習和運算生物學增強精準醫療。 Insilico Medicine 和 BenevolentAI 等新創公司正在透過人工智慧驅動的藥物開發平台獲得關注。此外，麻省理工學院和布羅德研究所等學術機構和研究中心在推動合成生物學和生物資訊學的發展方面發揮著至關重要的作用。合併、收購和策略合作夥伴關係正在塑造競爭格​​局，各公司正在合作利用人工智慧和生物分子的進步。政府資助和創投投資進一步推動創新，尤其是在北美和歐洲。然而，監管部門批准、資料隱私問題以及技術整合的高成本等挑戰繼續影響市場擴張和競爭。

最新動態：

2023 年 2 月，Peregrine Ventures 啟動新的「生物融合」新創公司，結合不同領域的技術來開發創新的生命科學產品。

2022 年 10 月，Century Therapeutics 與 Bristol Myers Squibb 合作開發和商業化 iPSC 衍生的同種異體細胞療法，透過再生治療領域的協作創新，增強其市場影響力並推進個人化醫療。

2022年5月，以色列啟動了一項為期5年、耗資1.27億美元的生物融合策略，重點關注工業研發和企業聯盟的基礎設施，將生物學與電子學、物理學、電腦科學和先進的基因工程相結合。

目錄

第 1 章：醫療保健生物融合市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 醫療保健生物融合市場片段（按技術）
    • 醫療保健生物融合市場片段（按解決方案類型）
    • 醫療保健生物融合市場片段（按應用）
    • 醫療保健生物融合市場片段（按最終用戶）
    • 醫療保健生物融合市場片段（按國家/地區）
    • 醫療保健生物融合市場片段（按區域）
  • 競爭洞察

第 3 章：醫療保健生物融合關鍵市場趨勢

  • 醫療保健生物融合市場促進因素
    • 市場促進因素的影響分析
  • 醫療保健生物融合市場限制
    • 市場限制的影響分析
  • 醫療保健生物融合市場機會
  • 醫療保健生物融合市場未來趨勢

第 4 章：醫療生物融合產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：醫療保健生物融合市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：醫療保健生物融合市場格局

  • 2024 年醫療保健生物融合市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：醫療保健生物融合市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 合成生物學
    • 生物電子學
    • 奈米科技
    • 人工智慧與巨量資料整合

第 8 章：醫療保健生物融合市場 - 按解決方案類型

  • 概述
    • 按解決方案類型分類的細分市場佔有率分析
    • 生物製藥
    • 組織工程
    • 生物感測器
    • 人工智慧診斷

第 9 章：醫療保健生物融合市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 藥物研發
    • 個人化醫療
    • 再生醫學
    • 生物電子學
    • 用於藥物輸送的奈米機器人
    • 診斷和生物感測器
    • 工程生物材料
    • 光遺傳學

第 10 章：醫療保健生物融合市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 生技公司
    • 研究機構
    • 診斷實驗室

第 11 章：醫療保健生物融合市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美醫療生物融合主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按技術分類）
    • 北美市場規模和預測，按解決方案類型
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲醫療生物融合主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模和預測（按技術分類）
    • 歐洲市場規模和預測，按解決方案類型
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區醫療生物融合主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依技術分類）
    • 亞太地區市場規模及預測（依解決方案類型）
    • 亞太地區市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲醫療生物融合主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依技術分類）
    • 拉丁美洲市場規模及預測（按解決方案類型）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲醫療生物融合主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模和預測（按技術分類）
    • MEA 市場規模和預測（按解決方案類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 12 章：主要供應商分析-醫療生物融合產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Adaptive Biotechnologies Corporation
    • Atomwise, Inc.
    • Berkeley Lights, Inc.
    • BGI Genomics Co., Ltd.
    • BioNTech SE
    • Codexis, Inc.
    • Deep Genomics Inc.
    • Ginkgo Bioworks Holdings, Inc.
    • Illumina, Inc.
    • Inscripta, Inc.
    • Moderna, Inc.
    • NanoString Technologies, Inc.
    • Oxford Nanopore Technologies plc
    • Pacific Biosciences of California, Inc.
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience Corporation
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4880

REPORT HIGHLIGHT

Healthcare Bioconvergence Market size was valued at US$ 143,920.32 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Healthcare Bioconvergence Market integrates biology, engineering, and data science to drive innovation in diagnostics, drug development, and personalized medicine. Bioconvergence refers to the fusion of biological and technological disciplines to enhance healthcare solutions. Advances in synthetic biology, nanotechnology, and artificial intelligence are transforming medical research and patient care. For instance, researchers at MIT have developed AI-powered drug discovery platforms that reduce development time by nearly 50%. The increasing prevalence of chronic diseases, demand for precision medicine, and government initiatives supporting biotech innovation are fueling growth. However, high R&D costs and regulatory complexities pose challenges. The emergence of bio-integrated wearable devices, lab-on-a-chip technology, and 3D bioprinting presents lucrative opportunities. Companies like Moderna and BioNTech are leveraging bioconvergence to enhance mRNA-based therapies, demonstrating the potential for disruptive innovations in treatment. Additionally, collaborations between biotech firms and semiconductor manufacturers, such as Intel's AI-driven healthcare initiatives, are expanding the market's technological scope. The future of healthcare bioconvergence lies in bridging biology with advanced computational and engineering solutions.

Healthcare Bioconvergence Market- Market Dynamics

**Advancements in AI-Powered Drug Discovery accelerating the market growth**

AI-powered drug discovery is revolutionizing the healthcare bioconvergence market by accelerating the identification of novel therapeutics and optimizing treatment development. Leading pharmaceutical firms and biotech startups are integrating AI with biological data to enhance precision medicine and streamline drug screening. For instance, the FDA has approved AI-driven platforms for drug repurposing, while companies like Insilico Medicine and BenevolentAI are utilizing deep learning to identify promising drug candidates. Moreover, AI-driven algorithms are being used in genomics to analyze vast datasets, aiding in early disease detection. The National Institutes of Health (NIH) has funded multiple AI-based research projects to improve drug efficacy and reduce development timelines. With AI reducing costs and enhancing efficiency, pharmaceutical companies are increasingly collaborating with tech firms to leverage machine learning in drug discovery. However, regulatory challenges and data privacy concerns remain key hurdles in fully realizing AI's potential in drug development. Despite these challenges, the ongoing convergence of AI and biotechnology is set to reshape modern medicine.

Healthcare Bioconvergence Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on Technology segmentation, AI & Big Data Integration was predicted to show maximum market share in the year 2024

Based on Solution Type segmentation, Biopharmaceuticals was the leading Solution Type in 2024

Based on Application segmentation, Personalized Medicine was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Healthcare Bioconvergence Market- Segmentation Analysis:

The Global Healthcare Bioconvergence Market is segmented on the basis of Technology, Solution Type, Application, End-User, and Region.

The market is divided into four categories based on Technology: Synthetic Biology, Bioelectronics, Nanotechnology, and AI & Big Data Integration. AI & Big Data Integration leads the healthcare bioconvergence market, driving personalized medicine and predictive analytics. Synthetic Biology follows, revolutionizing gene editing and biomaterials. Nanotechnology ranks next, enabling targeted drug delivery. Bioelectronics holds significant potential, enhancing neurostimulation and real-time health monitoring applications.

The market is divided into four categories based on Solution Type: Biopharmaceuticals, Tissue Engineering, Biosensors, and AI-driven Diagnostics. Biopharmaceuticals dominate the healthcare bioconvergence market, driving advancements in targeted therapies and regenerative medicine. AI-driven Diagnostics follows, revolutionizing early disease detection and precision medicine. Tissue Engineering ranks next, enabling organ regeneration. Biosensors play a crucial role in real-time monitoring and personalized healthcare solutions.

Healthcare Bioconvergence Market- Geographical Insights

North America dominates the healthcare bioconvergence market, driven by strong investments in biotechnology, artificial intelligence (AI), and precision medicine. The U.S., home to major biotech firms and research institutions, has seen increasing collaborations between pharmaceutical companies and AI-driven startups. Government initiatives, such as the NIH's AI-driven research programs, further support market growth. Europe follows closely, with countries like Germany, the UK, and France advancing in synthetic biology, bioengineering, and digital health innovations. The European Commission has launched funding programs to promote bioconvergence research. In the Asia-Pacific region, China, Japan, and South Korea are rapidly expanding their biotech and AI capabilities, fueled by government policies and private sector investments. China, in particular, is leading in gene editing and AI-driven diagnostics. Meanwhile, the Middle East and Latin America are emerging players, with growing investments in personalized medicine and bioinformatics. However, regulatory complexities and ethical concerns around AI and genetic modifications pose challenges to market expansion across different regions.

Healthcare Bioconvergence Market- Competitive Landscape:

The healthcare bioconvergence market is highly competitive, with key players focusing on integrating biotechnology, artificial intelligence (AI), nanotechnology, and engineering to drive medical innovations. Leading pharmaceutical companies such as Pfizer, Novartis, and Roche are investing in AI-powered drug discovery and bioengineering solutions. Tech firms like IBM Watson Health and Google DeepMind are enhancing precision medicine through machine learning and computational biology. Startups such as Insilico Medicine and BenevolentAI are gaining traction with AI-driven drug development platforms. Additionally, academic institutions and research centers, including MIT and the Broad Institute, are playing a crucial role in advancing synthetic biology and bioinformatics. Mergers, acquisitions, and strategic partnerships are shaping the competitive landscape, with companies collaborating to leverage AI and biomolecular advancements. Government funding and venture capital investments further drive innovation, particularly in North America and Europe. However, challenges such as regulatory approvals, data privacy concerns, and the high cost of technology integration continue to impact market expansion and competition.

Recent Developments:

In February 2023, Peregrine Ventures launched new 'bioconvergence' startups, combining technologies from diverse fields to develop innovative life sciences products.

In October 2022, Century Therapeutics and Bristol Myers Squibb partnered to develop and commercialize iPSC-derived allogenic cell therapies, enhancing their market presence and advancing personalized medicine through collaborative innovation in regenerative treatments.

In May 2022, Israel launched a five-year, $127 million bio-convergence strategy, focusing on infrastructure for industrial R&D and company consortiums to integrate biology with electronics, physics, computer science, and advanced genetic engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Atomwise, Inc.
  • Berkeley Lights, Inc.
  • BGI Genomics Co., Ltd.
  • BioNTech SE
  • Codexis, Inc.
  • Deep Genomics Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Illumina, Inc.
  • Inscripta, Inc.
  • Moderna, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Others

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Synthetic Biology
  • Bioelectronics
  • Nanotechnology
  • AI & Big Data Integration

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceuticals
  • Tissue Engineering
  • Biosensors
  • AI-driven Diagnostics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Personalized Medicine
  • Regenerative Medicine
  • Bioelectronics
  • Nanorobotics for Drug Delivery
  • Diagnostic and Biological Sensor
  • Engineered Living Materials
  • Optogenetics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotech Firms
  • Research Institutions
  • Diagnostic Labs

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Healthcare Bioconvergence Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Healthcare Bioconvergence Market Snippet by Technology
    • 2.1.2. Healthcare Bioconvergence Market Snippet by Solution Type
    • 2.1.3. Healthcare Bioconvergence Market Snippet by Application
    • 2.1.4. Healthcare Bioconvergence Market Snippet by End-User
    • 2.1.5. Healthcare Bioconvergence Market Snippet by Country
    • 2.1.6. Healthcare Bioconvergence Market Snippet by Region
  • 2.2. Competitive Insights

3. Healthcare Bioconvergence Key Market Trends

  • 3.1. Healthcare Bioconvergence Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Healthcare Bioconvergence Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Healthcare Bioconvergence Market Opportunities
  • 3.4. Healthcare Bioconvergence Market Future Trends

4. Healthcare Bioconvergence Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Healthcare Bioconvergence Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Healthcare Bioconvergence Market Landscape

  • 6.1. Healthcare Bioconvergence Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Healthcare Bioconvergence Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Synthetic Biology
    • 7.1.3. Bioelectronics
    • 7.1.4. Nanotechnology
    • 7.1.5. AI & Big Data Integration

8. Healthcare Bioconvergence Market - By Solution Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
    • 8.1.2. Biopharmaceuticals
    • 8.1.3. Tissue Engineering
    • 8.1.4. Biosensors
    • 8.1.5. AI-driven Diagnostics

9. Healthcare Bioconvergence Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Regenerative Medicine
    • 9.1.5. Bioelectronics
    • 9.1.6. Nanorobotics for Drug Delivery
    • 9.1.7. Diagnostic and Biological Sensor
    • 9.1.8. Engineered Living Materials
    • 9.1.9. Optogenetics

10. Healthcare Bioconvergence Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotech Firms
    • 10.1.4. Research Institutions
    • 10.1.5. Diagnostic Labs

11. Healthcare Bioconvergence Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Healthcare Bioconvergence Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Healthcare Bioconvergence Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Healthcare Bioconvergence Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Healthcare Bioconvergence Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Healthcare Bioconvergence Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Healthcare Bioconvergence Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Atomwise, Inc.
    • 12.2.3. Berkeley Lights, Inc.
    • 12.2.4. BGI Genomics Co., Ltd.
    • 12.2.5. BioNTech SE
    • 12.2.6. Codexis, Inc.
    • 12.2.7. Deep Genomics Inc.
    • 12.2.8. Ginkgo Bioworks Holdings, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Inscripta, Inc.
    • 12.2.11. Moderna, Inc.
    • 12.2.12. NanoString Technologies, Inc.
    • 12.2.13. Oxford Nanopore Technologies plc
    • 12.2.14. Pacific Biosciences of California, Inc.
    • 12.2.15. Thermo Fisher Scientific Inc.
    • 12.2.16. Twist Bioscience Corporation
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us